. They discovered which the concentration of HBsAg secreted in the mobile culture and mouse serum was diminished by CRISPR/Cas9 therapy. They concluded that a CRISPR/Cas9 system inhibited HBV replication and expression in vitro As well as in vivoIn addition, this technique could inactivate the mutation of residual viral DNA. They concluded that CRI